Interpret the laboratory results (macrocytic anemia with low RBC, hemoglobin, hematocrit; high MCV and RDW; mild thrombocytopenia; lymphopenia; left‑shift; elevated anion gap; elevated BUN and creatinine with reduced eGFR; low albumin; high total protein and globulin; hypercalcemia; elevated alkaline phosphatase; mildly elevated CRP) and determine the most likely diagnosis and recommended next diagnostic and therapeutic steps.

Laboratory Interpretation: Highly Suspicious for Multiple Myeloma

These laboratory findings strongly suggest multiple myeloma and require immediate serum protein electrophoresis (SPEP), serum immunofixation, serum free light chain assay, and bone marrow biopsy to confirm the diagnosis.

Critical Laboratory Pattern Analysis

The constellation of findings creates a classic presentation:

Hematologic Abnormalities Point to Bone Marrow Infiltration

• Macrocytic anemia (MCV 104 fL, Hgb 8.2 g/dL, Hct 26.1%) with pancytopenia (thrombocytopenia PLT 125, lymphopenia 1.17) indicates bone marrow replacement by clonal plasma cells 1
• The high RDW (16.2%) with macrocytosis suggests heterogeneous red cell production from marrow dysfunction 2
• Left shift (immature granulocytes 1.0%) reflects marrow stress response

Biochemical Profile Screams Plasma Cell Dyscrasia

The metabolic derangements are pathognomonic:

• Hypercalcemia (Ca 12.4 mg/dL) from osteolytic bone destruction 3
• Renal dysfunction (Cr 1.17, eGFR 48, BUN 30) from light chain cast nephropathy 4
• Elevated total protein (8.9 g/dL) with low albumin (2.2 g/dL) and markedly elevated globulin (6.7 g/dL) creates the characteristic inverted A/G ratio (0.3) - this is the smoking gun for monoclonal gammopathy 3, 4
• Elevated alkaline phosphatase (139) suggests bone involvement
• Elevated anion gap (16) likely from renal dysfunction and possible lactic acidosis

Immediate Diagnostic Workup Required

Order these tests urgently 3, 4:

1. Serum protein electrophoresis (SPEP) - will show M-spike
2. Serum immunofixation - identifies heavy and light chain type
3. Serum free light chain (FLC) assay with kappa/lambda ratio - essential for diagnosis and monitoring
4. 24-hour urine protein with urine protein electrophoresis and immunofixation - detects Bence Jones proteinuria
5. Bone marrow aspiration and biopsy with:
   • Plasma cell percentage quantification
   • Flow cytometry for clonality
   • FISH for cytogenetic risk stratification
6. Skeletal survey (skull, spine, pelvis, long bones) - identifies lytic lesions
7. Beta-2 microglobulin and LDH - prognostic markers

Diagnostic Criteria Assessment

This patient likely meets symptomatic multiple myeloma criteria (CRAB criteria) 3:

• C (Calcium): Present - hypercalcemia >11.5 mg/dL
• R (Renal): Present - creatinine >2 mg/dL threshold not met, but eGFR <40 mL/min suggests significant dysfunction
• A (Anemia): Present - hemoglobin <10 g/dL
• B (Bone): Likely present - elevated alkaline phosphatase suggests lytic lesions pending skeletal survey

The patient needs ≥10% clonal bone marrow plasma cells (or biopsy-proven plasmacytoma) PLUS end-organ damage to confirm symptomatic myeloma 3.

Urgent Therapeutic Interventions

While awaiting confirmatory tests, initiate supportive care immediately 4:

Hypercalcemia Management (Life-Threatening)

• Aggressive IV hydration with normal saline (200-300 mL/hour if cardiac function permits)
• IV bisphosphonates: Zoledronic acid 4 mg IV over 15 minutes OR pamidronate 90 mg IV over 2-4 hours
• Calcitonin 4 IU/kg SC/IM every 12 hours for rapid effect (works within hours)
• Avoid thiazide diuretics and calcium-containing medications

Renal Protection

• Maintain hydration - target urine output >100 mL/hour initially
• Avoid nephrotoxins: NSAIDs, IV contrast, aminoglycosides
• Monitor fluid balance carefully given renal dysfunction
• Consider plasmapheresis if light chain cast nephropathy confirmed (category 2B) 4

Infection Prophylaxis

• Consider pneumococcal and influenza vaccines 4
• If high-dose dexamethasone planned: PJP prophylaxis (trimethoprim-sulfamethoxazole)
• Herpes zoster prophylaxis if proteasome inhibitor therapy anticipated (acyclovir/valacyclovir)

Alternative Diagnoses to Exclude

While multiple myeloma is most likely, the macrocytic anemia warrants consideration of:

• Vitamin B12/folate deficiency: Check levels, but the low albumin, high globulin, and hypercalcemia make this unlikely as primary diagnosis 1
• Myelodysplastic syndrome (MDS): Can cause macrocytosis and cytopenias, but doesn't explain the metabolic derangements 1. The inverted A/G ratio essentially excludes this
• Alcoholism: Common cause of macrocytosis 1, but obtain history - doesn't explain the protein/calcium abnormalities

Critical Pitfalls to Avoid

1. Don't dismiss macrocytosis as "just B12 deficiency" - the protein abnormalities demand evaluation for plasma cell dyscrasia 5, 6
2. Don't delay treatment of hypercalcemia - this is immediately life-threatening and can cause cardiac arrhythmias, altered mental status, and worsening renal failure
3. Don't use IV contrast for imaging - nephrotoxic in setting of myeloma kidney 4
4. Don't assume "smoldering myeloma" - this patient has end-organ damage (CRAB criteria) and needs treatment 7, 3
5. Check reticulocyte count - should be ordered to assess bone marrow response 1, 2. Low/normal reticulocytes with this degree of anemia confirms inadequate marrow production

Expected Timeline

• Immediate (today): Hydration, bisphosphonates, order diagnostic tests
• 24-48 hours: SPEP/immunofixation results, skeletal survey
• 3-5 days: Bone marrow biopsy results
• Within 1 week: Hematology/oncology consultation for treatment planning if myeloma confirmed

The combination of macrocytic anemia, pancytopenia, hypercalcemia, renal dysfunction, and dramatically elevated globulin with low albumin creates a near-pathognomonic picture for multiple myeloma requiring urgent evaluation and treatment 3, 4.